Every year, World Cancer Day is celebrated on 4 February. This day aims to raise awareness of the situation of cancer patients and their families among the public, professionals, and policymakers through campaigns with different themes each year. Lectures, meetings, and concerts are organised during World Cancer Day.
We rarely see one world-altering revolution in cancer research, progress is made in several small, important steps in many different areas. Connecting these dots of improvements is where they together make a significant impact on patient outcomes.
We focus on making theragnostics a standard treatment option and an important part of cancer treatment in the Nordics and Baltics. Theragnostics may be unfamiliar to some, but it is not a new concept. It all started in 1913, when a radioactive substance, Radium, was injected into humans for the first time. In recent years, the theragnostic concept really started to gain wide interest when the first market-approved radioligand therapy was introduced. Research on this area has merely exploded during the last two decades. In 2003, 276 Pubmed.gov articles were published including the words theragnostics or theragnostics while in 2022 there were 20351 articles published. To say that theragnostics is gaining attention around the globe is an understatement.